Loxo Oncology Backtesting

Loxo Oncology Inc -- USA Stock  

USD 104.97  0.17  0.16%

With this equity back-testing module your can estimate the performance of a buy and hold strategy of Loxo Oncology Inc and determine expected loss or profit from investing in Loxo Oncology over given investment horizon. Please see also Loxo Oncology Hype Analysis, Loxo Oncology Correlation, Loxo Oncology Valuation, Loxo Oncology Volatility as well as analyze Loxo Oncology Alpha and Beta and Loxo Oncology Performance
 Time Horizon     30 Days    Login   to change

Loxo Oncology 'What if' Analysis

January 19, 2018
No Change 0.00  0.0%
In 30 days
February 18, 2018
If you would invest  0.00  in Loxo Oncology on January 19, 2018 and sell it all today you would earn a total of 0.00 from holding Loxo Oncology Inc or generate 0.0% return on investment in Loxo Oncology over 30 days. Loxo Oncology is related to or competes with NantKwest, Del Mar, Denali Therapeutics, and VBI Vaccines. Loxo Oncology, Inc., a biopharmaceutical company, develops and sells medicines for patients with genetically defined can...

Loxo Oncology Upside/Downside Indicators


Loxo Oncology Market Premium Indicators

Loxo Oncology Inc lagged returns against current returns

 Current and Lagged Values 

Loxo Oncology regressed lagged prices vs. current prices

 Current vs Lagged Prices 

Loxo Oncology Inc Backtested Returns

Macroaxis considers Loxo Oncology not too volatile given 1 month investment horizon. Loxo Oncology Inc has Sharpe Ratio of 0.1352 which conveys that Loxo Oncology Inc had 0.1352% of return per unit of risk over the last 1 month. Our philosophy towards estimating volatility of a stock is to use all available market data together with company specific technical indicators that cannot be diversified away. We have found twenty-one technical indicators for Loxo Oncology which you can use to evaluate future volatility of the firm. Please exercise Loxo Oncology Inc Downside Deviation of 2.5, Mean Deviation of 2.65 and Risk Adjusted Performance of 0.372 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100 Loxo Oncology holds performance score of 8. The company secures Beta (Market Risk) of 1.1438 which conveys that Loxo Oncology returns are very sensitive to returns on the market. as market goes up or down, Loxo Oncology is expected to follow.. Although it is vital to follow to Loxo Oncology Inc price patterns, it is good to be conservative about what you can actually do with the information regarding equity historical price patterns. The philosophy towards estimating future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. By analyzing Loxo Oncology Inc technical indicators you can presently evaluate if the expected return of 0.4234% will be sustainable into the future. Please exercises Loxo Oncology Inc Standard Deviation as well as the relationship between Value At Risk and Kurtosis to make a quick decision on weather Loxo Oncology Inc current price movements will revert.
Advice Volatility Trend Exposure Correlations
15 days auto-correlation 0.27 

Poor predictability

Loxo Oncology Inc has poor predictability. Overlapping area represents the amount of predictability between Loxo Oncology time series from January 19, 2018 to February 3, 2018 and February 3, 2018 to February 18, 2018. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Loxo Oncology Inc price movement. The serial correlation of 0.27 indicates that nearly 27.0% of current Loxo Oncology price fluctuation can be explain by its past prices.
Correlation Coefficient 0.27
Spearman Rank Test -0.03
Price Variance 26.56
Lagged Price Variance 4.61

Loxo Oncology Lagged Returns

 Regressed Prices 

Loxo Oncology Performance vs DOW

The median price of Loxo Oncology for the period between Fri, Jan 19, 2018 and Sun, Feb 18, 2018 is 100.92 with a coefficient of variation of 4.71. The daily time series for the period is distributed with a sample standard deviation of 4.68, arithmetic mean of 99.21, and mean deviation of 4.0. The Stock received some media coverage during the period.
Price Growth (%)  
Loxo Oncology Inc Position Lifted by Victory Capital Managem...02/16/2018